About the lab

We are curious about one big question: what do genetic changes actually do? Our lab moves beyond identifying genes and variants to experimentally uncovering their biological consequences. From cancer-driving alterations to rare genetic variants, we use functional genomics to turn genomic observations into biological understanding.

The lab was established at the American University of Beirut in 2025, bringing together years of experience in cancer genetics, CRISPR screening, and in vivo disease modeling. It started with a simple idea: build a research program where genomics meets experimentation, while creating opportunities for young scientists to ask ambitious questions and learn by doing.

We are a growing and collaborative group working at the intersection of genetics, cancer biology, and biotechnology. We combine CRISPR/Cas9 genome editing, molecular and cellular biology, transcriptomics, and in vivo models to study cancer and rare genetic diseases. We especially enjoy projects where the answer is not obvious, and where the right experiment can turn a genomic clue into a biological story.